Lenakast Lenalidomide 25mg

Lenakast 25mg capsules are prescribed for the treatment of various conditions, including multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma. Specifically, lenakast 25mg is recommended to manage a subtype of a myelodysplastic syndrome called deletion 5q mds, which involves the loss of a segment of chromosome 5. The active ingredient in lenakast 25mg capsule, lenalidomide, functions by supporting the body's immune system and targeting cancer cells directly. It hampers the multiplication of malignant cells, inhibits the growth of blood vessels associated with cancer, and prompts the immune system to attack cancer cells. Lenakast works by exterminating abnormal cells in the bone marrow and restoring the production of normal blood cells.